Vilazodone Dosing Guidelines
Vilazodone should be initiated at 10 mg once daily with food for 7 days, then increased to 20 mg once daily for 7 days, and finally titrated to the target dose of 40 mg once daily, with no dose adjustments required for renal impairment, hepatic impairment, or elderly patients. 1
Standard Adult Dosing
- Initial dose: 10 mg once daily with food for 7 days 1
- Week 2: Increase to 20 mg once daily with food for 7 days 1
- Maintenance dose: 40 mg once daily with food 1
Critical administration requirement: Vilazodone must be taken with food to ensure adequate plasma concentrations and therapeutic efficacy 2. The incremental dose titration is necessary to minimize gastrointestinal adverse effects, particularly nausea, vomiting, and diarrhea 1, 2.
Renal Impairment
No dosage adjustment is necessary for any degree of renal impairment 1. This recommendation applies across the full spectrum of renal dysfunction:
- Mild to moderate renal impairment (GFR 30-90 mL/min/1.73 m²): Standard dosing 1
- Severe renal impairment (GFR 15-30 mL/min): Standard dosing 1
Pharmacokinetic studies demonstrated that vilazodone exposure (Cmax and AUC) was similar in patients with mild or moderate renal impairment compared to healthy controls, with no systematic trends associated with decreasing renal function 3. Vilazodone undergoes extensive hepatic metabolism with minimal renal excretion (mean urinary recovery <1% of dose), explaining why renal function does not significantly impact drug clearance 3.
Hepatic Impairment
No dosage adjustment is necessary for any degree of hepatic impairment 1. This applies to:
- Mild hepatic impairment (Child-Pugh A): Standard dosing 1
- Moderate hepatic impairment (Child-Pugh B): Standard dosing 1
- Severe hepatic impairment (Child-Pugh C): Standard dosing 1
Pharmacokinetic studies showed that following a single 20 mg dose, vilazodone pharmacokinetics were similar across all degrees of hepatic impairment compared to healthy controls 4. In severe hepatic impairment, mean Cmax and AUC were approximately 29% and 17% lower (not higher) than in healthy subjects, with similar half-life and Tmax values 4.
Elderly Patients
No dosage adjustment is recommended based on age alone 1. Pharmacokinetic studies comparing geriatric subjects (>65 years) to younger adults (24-55 years) demonstrated similar pharmacokinetics between age groups 1.
Important considerations for elderly patients:
- Start at the low end of the dosing range (10 mg daily) as a conservative approach, given the greater frequency of decreased hepatic, renal, or cardiac function in this population 1
- Monitor closely for hyponatremia, as serotonergic antidepressants have been associated with clinically significant hyponatremia in elderly patients who may be at greater risk 1
- Follow standard titration schedule to target dose of 40 mg daily 1
Drug Interactions Requiring Dose Adjustment
When co-administered with strong CYP3A4 inhibitors (e.g., ketoconazole), reduce vilazodone dose to 20 mg once daily 2. Vilazodone is extensively metabolized by CYP3A4, and strong inhibitors can significantly increase drug exposure 2.
Pediatric Dosing
The maximum dose tested in pediatric patients was 30 mg daily 1. Common adverse reactions in pediatric patients (≥5% and at least twice placebo rate) included nausea, vomiting, diarrhea, abdominal pain/discomfort, and dizziness 1.
Common Pitfalls to Avoid
- Do not initiate at 40 mg: Rapid titration increases gastrointestinal adverse effects 1, 2
- Do not administer without food: This results in inadequate plasma concentrations and reduced efficacy 2
- Do not assume dose reduction is needed in renal/hepatic impairment: Unlike many medications, vilazodone requires no adjustment 1
- Do not overlook hyponatremia risk in elderly: Monitor electrolytes, particularly in older patients 1